AntriaBio Inc.'s stockholders approved a proposal for a reverse stock split of the company's outstanding common shares.

At the Nov. 28 annual meeting, stockholders approved the proposal to implement a reverse stock split at a ratio between 2-to-1 and 5-to-1, which will be effective on or before Sept. 30, 2018.

The final ratio and the effective date of the stock split will be determined by the company's board.